Abstract:Introduction : Oral drug delivery is the most favored route of drug administration. However, poor oral bioavailability is one of the leading reasons for insufficient clinical efficacy. Improving oral absorption of drugs with low water solubility and/or low intestinal membrane permeability is an active field of research. Cocrystallization of drugs with appropriate coformers is a promising approach for enhancing oral bioavailability. Methods : In the present review, we have focused on recent advances that have been made in improving oral absorption through cocrystallization. The covered areas include supersaturation and its importance on oral absorption of cocrystals, permeability of cocrystals through membranes, drug-coformer pharmacokinetic (PK) interactions, conducting in vivo-in vitro correlations for cocrystals. Additionally, a discussion has been made on the integration of nanocrystal technology with supramolecular design. Marketed cocrystal products and PK studies in human subjects are also reported. Results : Considering supersaturation and consequent precipitation properties is necessary when evaluating dissolution and bioavailability of cocrystals. Appropriate excipients should be included to control precipitation kinetics and to capture solubility advantage of cocrystals. Beside to solubility, cocrystals may modify membrane permeability of drugs. Therefore, cocrystals can find applications in improving oral bioavailability of poorly permeable drugs. It has been shown that cocrystals may interrupt cellular integrity of cellular monolayers which can raise toxicity concerns. Some of coformers may interact with intestinal absorption of drugs through changing intestinal blood flow, metabolism and inhibiting efflux pumps. Therefore, caution should be taken into account when conducting bioavailability studies. Nanosized cocrystals have shown a high potential towards improving absorption of poorly soluble drugs. Conclusions : Cocrystals have found their way from the proof-of-principle stage to the clinic. Up to now, at least two cocrystal products have gained approval from regulatory bodies. However, there are remaining challenges on safety, predicting in vivo behavior and revealing real potential of cocrystals in the human.

Current Strategies for Oral Delivery of BCS IV Drug Nanocrystals: Challenges, Solutions and Future Trends.

Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling

Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors

Nanocrystal technology for drug formulation and delivery

Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics

Recent developments in the use of nanocrystals to improve bioavailability of APIs

Nanocrystals Technology for Pharmaceutical Science.

State of the art of nanocrystals technology for delivery of poorly soluble drugs

Advances of Combinative Nanocrystal Preparation Technology for Improving the Insoluble Drug Solubility and Bioavailability

Recent advances in improving oral drug bioavailability by cocrystals

Strategies and methods of nanocrystal technology for targeting drug delivery

Nanosized Drug Delivery for Enhancement of Oral Bioavailability

Chitosan Nanoparticles in Oral Drug Delivery: A comprehensive and equivocal review

Recent Trends in Nanocrystals for Pharmaceutical Applications.

Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system

Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment.

What Is The Future For Nanocrystal-Based Drug-Delivery Systems?

Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery

Crystallization Methods for Preparation of Nanocrystals for Drug Delivery System

Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs

Nanocrystals and nanosuspensions: an exploration from classic formulations to advanced drug delivery systems